Viewing Study NCT05954468


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-01 @ 5:40 PM
Study NCT ID: NCT05954468
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2023-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Psycho-social Impact of Anti-NMDAR Encephalitis
Sponsor: Hospices Civils de Lyon
Organization:

Study Overview

Official Title: Psycho-social Impact of Anti-NMDAR Encephalitis
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SAPIENCE
Brief Summary: NMDA receptor encephalitis is a rare neurological autoimmune disease with severe neuropsychiatric symptoms, but a typically good functional neurological outcome. The majority of patients experience long-term cognitive, psychological and social impairments that have significant consequences for their well-being and quality of life. However, as the disease was only recently discovered (Dalmau and al. Annals of neurology, 2007), this psycho-social impact has not been studied systematically and the resulting consequences for patients are not adequately appreciated.

The proposed study aims at characterizing the cognitive and psycho-social long-term consequences of this rare disease. Our main hypothesis is that NMDAR encephalitis has a persistent and clinically relevant impact on the patients' long-term cognitive, psychological and social well-being. Furthermore, we hypothesize that longterm subjective outcomes depend on both internal and external factors, such as acute disease course, access to post-acute care, caregiver support, personal coping strategies, or access to health education resources and peer group support.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: